Pharmaceutical Fraud

Hagens Berman vigorously pursues litigation that improves the quality and fairness of our healthcare and prescription drug system. Representing classes of consumers, state and local governments and the nation's most forward-thinking public-interest groups, we seek to shine the light of public scrutiny on these industries and their practices.

Our pharmaceutical fraud attorneys have filed and argued suits against dozens of major drug companies, giving them extensive litigation and courtroom experience.

Some of the areas covered by our practice include:

Off-label marketing: Federal law prohibits companies from marketing medical devices or drugs for uses not approved by the Food and Drug Administration. We have negotiated a number of major settlements in this area, recovering funds for consumers as well as state Medicaid plans, which purchased the drugs for purposes not endorsed by the FDA.

Personal injury: When pharmaceutical or compounding companies are negligent in releasing and distributing dangerous drugs to the public, we take legal action, pursuing justice for patients.

Pricing fraud: We have negotiated over a billion dollars in settlements on behalf of clients, including consumers and governments, who we alleged overpaid for drugs due to price-inflation schemes. No firm in the world matches our experience in this arena.